1. Thierry Langer is Full Professor of Medicinal Chemistry at the University of Vienna (Austria). He is also visiting professor and faculty member of King Abdulaziz University (Jeddah, Saudi Arabia) and CEO of Prestwick Chemical (Strasbourg-Illkirch, France). His research interests range from medicinal to computational chemistry, including drug design, pharmacophore modeling as well as QSAR and 3D-QSAR molecular modeling techniques. His scientific work has culminated in several patents and more than 180...
2. Sharon D Bryant is CEO of Inte:Ligand GmbH (Vienna, Austria), a company providing scientific modeling software and research consulting for the life science industry. Previously, she was Senior Research Scientist at the NIH, actively involved in molecular modeling of novel opioid peptide derivatives, opioid G-protein-coupled receptors, and development of pharmacophores to identify structural templates for novel lead compounds for investigative research and therapeutic drugs. She has authored more than 60...